Effect of vitamin D on prostate

Effect of vitamin D on biochemical indicators and clinical symptoms in military personnel with benign prostatic hyperplasia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180201038585N9

Enrollment

Registered

2020-11-02

Start date

2020-10-22

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia. Enlarged prostate

Interventions

Intervention 1: Intervention group:There are 30 people in this group who are studied once a week for 8 weeks using a vitamin D supplement containing 50,000 international units of D3. Drugs and placebo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Suffered from BPH based on the diagnosis of a clinical specialist Signing of a informed consent form

Exclusion criteria

Exclusion criteria: Allergy to vitamin D

Design outcomes

Primary

Measure	Time frame
Serum levels of prostate-specific antigen (PSA). Timepoint: At the beginning of the study and 56 days after weekly intake of vitamin D. Method of measurement: Using a specific kit.	—

Secondary

Measure	Time frame
Serum levels of vitamin d. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of calcium and phosphorus. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of testosterone and LH. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Size of prostate. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using sonogrphy.;Clinical signs of prostate hyperplasia. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: Using a validated questionnaire.	—

Measure

Time frame

Serum levels of vitamin d. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of calcium and phosphorus. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of testosterone and LH. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Size of prostate. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using sonogrphy.;Clinical signs of prostate hyperplasia. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: Using a validated questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarim Parastouei

Bagheiat-allah University of Medical Sciences

parastouei@bmsu.ac.ir+98 21 8248 3516

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026